Search
News
Pixelworks Q2 2026 earnings: Revenue falls as operating loss widens
Pixelworks (NASDAQ: PXLW) reported Q2 2026 revenue of $64,000, down about 60% from $159,000 a year earlier, while its GAAP loss from continuing operations widened to $2.80 million from $2.58 million. The diluted continuing-operations loss per share narrowed to $0.44 from $0.49 as the weighted-average share count increased. Gross margin fell to about 60.9%, operating expenses rose to $3.40 million, and the operating loss widened to $3.36 million. Cash ended the quarter at $52.89 million following the company’s transition to a pure-play technology licensing model.
TradingKey
Tue, Aug 11
Smart Sand Q2 2026 earnings: Record volumes drive operating profit
Smart Sand’s Q2 2026 revenue rose about 34% year over year to $115.1 million as record sales volume reached 1.864 million tons. GAAP diluted EPS was $0.25 versus $0.54, but the decline reflected a large prior-year tax benefit; operating income improved to $10.1 million and adjusted EBITDA climbed to $18.7 million. Operating cash flow turned positive at $3.4 million, while $4.8 million of capital spending left free cash flow at negative $1.4 million. The company expects 2026 sales volumes to grow 10% to 20% and full-year free cash flow to be positive.
TradingKey
Tue, Aug 11
TherapeuticsMD Q2 2026 Earnings: License Revenue and Net Income Decline
TherapeuticsMD reported Q2 2026 license revenue of $864,000, down from $952,000 a year earlier, as sales of licensed products changed. Net income from continuing operations fell to $164,000 from $545,000, while operating expenses rose to $1.685 million. Cash and cash equivalents were $9.2 million at June 30, 2026. An IMVEXXY milestone of CAD 500,000, approximately US$364,800, will be recognized in Q3, and the company continues evaluating strategic alternatives without a timetable. The quarter highlighted dependence on licensee product sales and uneven milestone timing.
TradingKey
Tue, Aug 11
PLAYSTUDIOS Q2 2026 earnings: Legacy weakness widens losses
PLAYSTUDIOS reported Q2 2026 revenue of $55.0 million, down 7.3% year over year, as pressure on its legacy social casino portfolio outweighed rapid direct-to-consumer growth. The GAAP net loss widened to $13.3 million, or $0.10 per diluted share, while non-GAAP consolidated AEBITDA fell to $7.3 million and its margin contracted to 13.3%. Management is reducing the pace of investment in newer initiatives and completing its Renewal restructuring, which is intended to lower fixed costs, improve profitability, and support more stable cash generation.
TradingKey
Tue, Aug 11
Ambiq Q2 2026 earnings: Revenue rises 90% as gross margin expands
Ambiq Micro’s Q2 2026 net sales rose 89.7% year over year to $33.9 million, while GAAP gross margin expanded 4.9 percentage points to 45.0%. The company still posted a $7.1 million GAAP net loss, although non-GAAP net loss narrowed to $1.8 million. Operating expenses absorbed nearly all of the gross-profit increase, and six-month operating cash use widened as receivables and inventory grew. Q3 guidance calls for $36 million to $37 million of sales, with supply availability limiting upside and planned investment lifting adjusted operating expense.
TradingKey
Tue, Aug 11
Middleby Q2 2026 earnings: Revenue grows 10% as GAAP EPS declines
Middleby’s Q2 2026 earnings showed net sales of $875.5 million, up 9.9% year over year, while diluted GAAP EPS from continuing operations fell to $1.20 from $1.91. Adjusted EBITDA increased to $193.2 million, but its margin narrowed to 22.1% as transaction costs and weaker segment margins offset revenue growth. Commercial Foodservice delivered 8.3% organic sales growth. Following the Food Processing spin-off, Middleby raised its 2026 outlook for the post-spin company, forecasting full-year net sales of $2.48 billion to $2.53 billion.
TradingKey
Tue, Aug 11
Vestis Fiscal Q3 2026 Earnings: Pricing and Cost Actions Expand Margins
Vestis reported fiscal Q3 2026 revenue of $661.7 million, down 1.8%, while diluted EPS improved to $0.08 from a $0.01 loss. Adjusted EBITDA rose to $80.9 million and margin expanded to 12.2% from 9.5% as pricing, mix, and transformation savings offset a 4.5% decline in processed volume. Operating cash flow reached $64.9 million, and Vestis raised fiscal 2026 free cash flow guidance to $160 million-$170 million while narrowing adjusted EBITDA guidance to $310 million-$315 million. The company also repaid $30 million of debt during the quarter.
TradingKey
Tue, Aug 11
Terrestrial Energy Q2 2026 Earnings: Wider Net Loss Despite Licensing Progress
Terrestrial Energy (NASDAQ: IMSR) reported a Q2 2026 net loss of $9.4 million, versus $6.2 million a year earlier, while diluted loss per share narrowed to $0.09 from $0.10 because the weighted-average share count was higher. Operating expenses rose to $11.7 million, but $2.4 million of other income partly offset the operating loss. The company ended June with $283.4 million in cash, equivalents and investments, secured control of 77 acres at Texas A&M-RELLIS, and raised estimated lifetime revenue per IMSR Plant to $2.7 billion.TradingKey
Tue, Aug 11
Xtant Medical Q2 2026 Earnings: Revenue Declines as Margins Contract
Xtant Medical’s Q2 2026 revenue fell to $23.0 million from $35.4 million, while diluted EPS swung to a $0.07 loss from $0.02 of profit. Gross margin contracted to 57.9% from 68.6%, and adjusted EBITDA moved to a $2.7 million loss as divestitures, the end of high-margin license revenue, production inefficiencies, and inventory charges weighed on results. The company also incurred a $5.0 million Dilon-related exclusivity fee and reduced full-year 2026 revenue guidance to $99 million-$103 million amid softer biologics revenue and amnio reimbursement headwinds.
TradingKey
Tue, Aug 11
908 Devices Q2 2026 earnings: Revenue rises 23% as EBITDA loss narrows
908 Devices (NASDAQ: MASS) reported Q2 2026 revenue of $16.1 million, up 23% year over year, while its GAAP loss per share from continuing operations narrowed to $0.32 from $0.36. Gross margin improved to 52%, and the adjusted EBITDA loss fell by more than half to $1.9 million as VipIR shipments, NIRLab revenue, and a favorable product and channel mix supported results. The company raised the low end of its 2026 revenue outlook, now guiding to $68 million to $70 million, or 21% to 25% annual growth.
TradingKey
Tue, Aug 11
ECARX Q2 2026 Earnings: Gross Margin Rises to 19.8% as Product Mix Improves
ECARX reported Q2 2026 revenue of US$225.2 million, up 45% year over year, as higher-value computing platforms, overseas demand and pricing adjustments outweighed broadly flat shipments. Gross margin expanded to 19.8% from 10.8%, while net loss narrowed to US$12.0 million from US$45.4 million. The company posted a fourth consecutive quarter of positive adjusted EBITDA and reiterated full-year revenue guidance of US$1.0 billion to US$1.1 billion, though management warned that memory costs and strategic investments could pressure profitability in coming quarters.
TradingKey
Tue, Aug 11
Cardinal Q2 2026 Earnings: Revenue Doubles While Margins Contract
Cardinal Infrastructure Group’s Q2 2026 revenue rose 114% to $226.9 million, including 64% organic growth, while diluted EPS fell to $0.26 from $0.53. Adjusted EBITDA increased 43% to $28.1 million, but margin contracted to 12.4% from 18.6% as labor, equipment rental, weather, and corporate investment raised costs. Backlog reached $866 million, and Cardinal raised 2026 revenue guidance to $880 million-$900 million. The pending $120 million Allied Paving acquisition would add approximately $108 million of annual revenue and expand in-house paving capabilities in Atlanta.
TradingKey
Tue, Aug 11
Janus Q2 2026 earnings: Revenue rises as adjusted EBITDA margin contracts
Janus International Group’s fiscal Q2 2026 revenue rose 2.4% to $233.5 million, while diluted EPS fell to $0.08 from $0.15. Adjusted EBITDA declined 18.0% to $40.2 million and its margin contracted 430 basis points to 17.2%. Self-storage revenue grew 15.4%, helped by $19.2 million from Kiwi II Construction, but commercial and other revenue fell 21.2%. Janus updated full-year guidance to revenue of $925 million to $945 million and adjusted EBITDA of $150 million to $170 million.
TradingKey
Tue, Aug 11
Cardinal Health Q4 FY2026 Earnings: Revenue Rose 6% as Margins Expanded
Cardinal Health’s fiscal Q4 2026 revenue rose 6% to $63.7 billion, while GAAP diluted EPS increased 70% to $1.70 and non-GAAP diluted EPS climbed 40% to $2.91. A one-time IEEPA tariff refund contributed $0.31 to EPS; excluding it, non-GAAP EPS grew 25% to $2.60. Pharmaceutical and Specialty Solutions drove most revenue growth, while GMPD’s reported profit benefited heavily from the refund. Cardinal Health also introduced fiscal 2027 non-GAAP EPS guidance of $12.40 to $12.60, representing 13% to 15% growth from an adjusted fiscal 2026 base.
TradingKey
Tue, Aug 11
Venture Global Q2 2026 earnings: Plaquemines lifts revenue and margins
Venture Global’s Q2 2026 earnings showed revenue of $4.578 billion, up 48% year over year, and diluted EPS of $0.51 versus $0.14. Net income attributable to common stockholders reached $1.347 billion, while adjusted EBITDA rose 79% to $2.491 billion as Plaquemines commissioning increased LNG volumes and implied liquefaction fees. The company raised 2026 adjusted EBITDA guidance to $8.7 billion-$9.1 billion and narrowed its expected export range to 500-518 cargos, with Plaquemines Phase 1 commercial operations still targeted for Q4 2026.
TradingKey
Tue, Aug 11
Aramark Q3 FY2026 earnings: Revenue rises 9% as margins expand
Aramark’s fiscal Q3 2026 revenue rose 9% to $5.058 billion, operating income increased 18% to $216 million, and GAAP EPS climbed 34% to $0.36. Adjusted operating income reached $261 million, up 13% on a constant-currency basis, as new business, client retention, supply-chain efficiencies, and cost management supported results. A prior-year calendar shift held back reported comparisons. Aramark raised its fiscal 2026 organic revenue growth outlook to 9%-10% while reaffirming its adjusted operating income, adjusted EPS, and leverage targets.
TradingKey
Tue, Aug 11
DarioHealth Q2 2026 earnings: Margin expands despite lower revenue
DarioHealth (NASDAQ: DRIO) reported Q2 2026 revenue of $5.2 million, down from $5.4 million a year earlier as it moved away from certain pharmaceutical-related work. Gross margin rose to 61.7% from 55.2%, while operating expenses fell 21% and the GAAP operating loss narrowed to $6.5 million. The company ended June with about $14.0 million in cash, equivalents and short-term deposits, then raised $22.8 million net in July. New multi-condition contracts and customer expansions are expected to contribute later in 2026 and more meaningfully in 2027.TradingKey
Tue, Aug 11
Flowco Q2 2026 Earnings: Production Solutions Drives 22% Revenue Growth
Flowco’s Q2 2026 revenue rose 22.1% to $235.9 million, while diluted EPS increased to $0.28 from $0.21. Adjusted EBITDA reached $93.9 million at a 39.8% margin, and free cash flow was $49.8 million. Production Solutions supplied nearly all of the year-over-year revenue increase, helped sequentially by higher Downhole Components activity and two additional months of Valiant contribution. However, higher Surface Equipment maintenance and operating costs reduced that segment’s margin from the first quarter, while Natural Gas Technologies revenue was roughly flat year over year.
TradingKey
Tue, Aug 11
Huya Q2 2026 earnings: Game-related revenue drives 11% growth
Huya’s Q2 2026 net revenue rose 11.0% year over year to RMB1.74 billion as game-related services, advertising and other revenue jumped 54.1%, offsetting a decline in live streaming. Gross margin improved to 14.7% from 13.5%, and the GAAP operating loss narrowed to RMB7.0 million. Diluted earnings per ADS turned positive at RMB0.01, but non-GAAP net income fell to RMB36.4 million as interest income declined sharply. The quarter highlights Huya’s shift toward game publishing and related monetization alongside higher promotional spending.
TradingKey
Tue, Aug 11
Sable Q2 2026 Results: First Full Revenue Quarter Faces Midstream Constraints
Sable Offshore’s Q2 2026 results marked its first full quarter of revenue generation, with $137.1 million in revenue and $9.4 million of operating cash flow. Average net sales were about 21,000 barrels per day, while the company exited the quarter at roughly 40,000 net barrels per day. The ramp was constrained by downstream capacity and crude-quality discounts, contributing to $18.5 million of non-recurring demurrage charges. Sable also cut the midpoint of second-half 2026 capital spending guidance by 41% to $85 million as it prioritized cash flow and debt amortization.
TradingKey
Mon, Aug 10
Featured Tools
Top News
The Week Ahead: Fed Minutes, Walmart, Target and Home Depot Earnings to Test US Consumer Resilience
Broadcom Stock Price Forecast: Can It Break $500 Before Earnings Amid Strong Custom AI Chip Demand?
SK Hynix Stock Forecast: Can HBM4 Demand Drive a Breakout Toward $194?
Palantir Calls Q2 "Otherworldly" and Raises Guidance — Will Jackson Hole Derail the AI Sovereignty Momentum?
Tesla Stock Price Prediction: SpaceX Thruster-Equipped Roadster May Debut This Month, Could It Boost TSLA Stock?
